In the BioHarmony Drug Report Database
Zalcitabine
Hivid (zalcitabine) is a small molecule pharmaceutical. Zalcitabine was first approved as Hivid on 1992-06-19. It is used to treat acquired immunodeficiency syndrome in the USA.
Trade Name
|
Hivid |
|---|---|
Common Name
|
zalcitabine |
ChEMBL ID
|
CHEMBL853 |
Indication
|
acquired immunodeficiency syndrome |
Drug Class
|
Nucleoside antiviral or antineoplastic agents, cytarabine or azarabine derivatives |
Image (chem structure or protein)